Rockville, MD · Founded 2005 · Privately Held (backing)
Operator of a clinical-stage biotechnology company intended to design long shelf-life platelet-derived therapeutics. CellPhire Therapeutics is based in Rockville, MD and was founded in 2005. Its last reported valuation was $105 million in Mar 2021. It has raised $51.2 million.
Last reported valuation
$105.3M
Oct 2026
Priced at
—
Total raised
$51.2M
Last round
—
Cap table — not yet on record
CellPhire Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CellPhire Therapeutics with a free account
·Watch CellPhire Therapeutics: the Monday email on marks, rounds and moves
